Uploads Contact
/
Login Upload

  • Search Results for 'Parp Inhibitors And Cancer What Do You Need To Know'

PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
ellena-manuel
The Use of PARP Inhibitors in Breast Cancer: Challenges
The Use of PARP Inhibitors in Breast Cancer: Challenges
calandra-battersby
PARP Inhibitors and Cancer: What Do You Need to Know?
PARP Inhibitors and Cancer: What Do You Need to Know?
pasty-toler
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
conchita-marotz
CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
min-jolicoeur
Case Discussion: Second
Case Discussion: Second
celsa-spraggs
Cancer Chemotherapy Part I: General Cancer Chemotherapy
Cancer Chemotherapy Part I: General Cancer Chemotherapy
ellena-manuel
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
yoshiko-marsland
Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer
Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer
min-jolicoeur
A Cancer
A Cancer
stefany-barnette
Updates in Ovarian Cancer Care
Updates in Ovarian Cancer Care
tatiana-dople
Updates in Ovarian Cancer Care
Updates in Ovarian Cancer Care
ellena-manuel
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
calandra-battersby
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
marina-yarberry
Patient Selection for PARP
Patient Selection for PARP
sherrill-nordquist
State of the Art in BRCA
State of the Art in BRCA
ellena-manuel
The Nurse View: Clinical Considerations in the Management of
The Nurse View: Clinical Considerations in the Management of
natalia-silvester
Precision Medicine in the management of gynecologic cancers
Precision Medicine in the management of gynecologic cancers
stefany-barnette
Comparative effect of Various HDAC-inhibitors in-vitro on T
Comparative effect of Various HDAC-inhibitors in-vitro on T
pasty-toler
What’s Positive about Triple Negative Breast Cancer
What’s Positive about Triple Negative Breast Cancer
myesha-ticknor
Targeting endocrine-resistance pathways in breast cancer
Targeting endocrine-resistance pathways in breast cancer
alexa-scheidler
The MET oncogene:
The MET oncogene:
cheryl-pisano
The effect of inhibitors (Inorganic phosphate & Sodium
The effect of inhibitors (Inorganic phosphate & Sodium
alexa-scheidler
Anticancer Therapy:
Anticancer Therapy:
stefany-barnette